What Has Been The Evolution of the Genital Warts Market in Recent Years?
The genital warts market has seen considerable growth due to a variety of factors.
• The genital warts market has shown strong growth in recent years. It is expected to rise from $1.97 billion in 2024 to $2.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%.
Historical growth is due to an increased focus on patient-centered care, an emphasis on early detection and treatment, the availability of therapies for self-target applications, and more clinical trials addressing the recurrence of genital warts.
What Are the Future Growth Projections for the Genital Warts Market?
The genital warts market is expected to maintain its strong growth trajectory in upcoming years.
• The genital warts market is expected to grow steadily, reaching $2.57 billion by 2029, at a CAGR of 5.4%.
Factors driving this growth include the adoption of telemedicine and digital health platforms for remote consultations, rising demand for effective and affordable STI treatments, the growing popularity of loop electrosurgical excision procedures, increased demand for interferon alfa-n3 injections, and a greater availability of therapies. Key trends include advancements in diagnostic technologies, a shift toward combination therapies, expansion of telehealth, the emergence of new therapeutic targets, and market expansion in emerging regions.
What Are The Core Factors Supporting Growth In The Genital Warts Market?
The genital warts market is set to grow due to the rising prevalence of sexually transmitted infections (STIs). STIs are becoming more common, partly due to increased sexual activity, inadequate protection use, and limited access to education and healthcare. Genital warts, caused by specific strains of the human papillomavirus (HPV), spread through sexual contact. According to the Joint United Nations Programme on HIV/AIDS, in 2022, 39 million people were living with HIV, up from 38.7 million in 2021, with 1.3 million new infections. Therefore, the increasing rates of STIs are driving the growth of the genital warts market.
What Are The Major Segments Within The Global Genital Warts Market?
The genital warts market covered in this report is segmented –
1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid
2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments
3) By Gender: Female, Male
4) By End Users: Hospitals, Clinics, Home Care Settings
Subsegmments
1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%
2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%
3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%
4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%
Pre-Book The Genital Warts Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Genital Warts Market?
Leading firms in the genital warts market are progressing in the creation of innovative treatments like cutting-edge dermatology drugs, to confront the struggles experienced by genital warts patients. These dermatology drugs encompass the recently developed pharmaceuticals or therapeutic solutions, specifically created to cure various skin ailments including genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical organization based in the US, was granted New Chemical Entity (NCE) status for its investigational drug YCANTH. This drug, which is being developed for the treatment of genital warts, has successfully completed phase 2 trials. Thanks to the FDA NCE status, the company now has a minimum of five years of immunity from generic competitors.
Who Are the Key Players In The Genital Warts Market?
Major companies operating in the genital warts market are:
• Merck & Co.Inc.
• AbbVie Inc
• Sanofi S.A
• Novartis AG
• 3M Company
• Teva Pharmaceutical Industries Ltd
• Bausch Health Companies Inc
• Sun Pharmaceuticals
• Perrigo Company plc
• Glenmark Pharmaceutical Inc
• Taro Pharmaceutical Industries Ltd
• Serum Institute of India Pvt. Ltd.
• ANI Pharmaceuticals Inc
• Ligand Pharmaceuticals Incorporated
• Orgenesis Inc
• Verrica Pharmaceuticals Inc
• CryoConcepts LP
• CryoIQ global AB
• Cassiopea Inc
• Aresus Pharma Inc.
What Is The Most Dominant Region In The Genital Warts Market?
North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
